While markets remain dominated by AI hype, high-growth narratives, and momentum-driven capital flows, a quieter rotation is beginning beneath the surface. Dividend ETFs—often overlooked during aggressive bull cycles—are now sitting in a rare position where many defensive income strategies have lagged despite stable fundamentals. This newsletter explores why funds like $SPLV ( ▲ 0.18% ), $XLV ( ▼ 0.13% ), $VHT ( ▲ 0.27% ), $PPH ( ▲ 0.14% ), and $MORT ( ▲ 1.11% ) may be entering a period where valuation compression, policy uncertainty, and interest-rate expectations create potential long-term opportunity zones for disciplined income investors. In a market obsessed with speed, the real shift may be happening in the segments that nobody is paying attention to right now.

Mark Spitznagel, who made $1B in a single day during the 2015 flash crash, warned markets are mimicking 1929. Seems extreme but we did just see the worst quarter for the S&P since 2022.

So it’s not so surprising that Vanguard and Goldman Sachs forecasted 5% and 3% annual S&P returns respectively for 2024-2034.

Late last year, Apollo’s chief economist Torsten Slok put it this way: "expect zero in return in the S&P 500 over the coming decade."

So, what’s something investors can actually do to diversify this week?

Almost no one knows this, but postwar and contemporary art appreciated 10.2% annually with near-zero correlation to equities from 1995–2025 overall.*

And sure… billionaires like Bezos can make headlines at auction, but what about the rest of us?

Masterworks makes it possible to invest in legendary artworks by Banksy, Basquiat, Picasso, and more – without spending millions.

29 exits. Net annualized returns like 16.5%, 17.6%, and 17.8% on works held over 1 year+. $1.3 billion invested. 500+ offerings.*

Shares in new offerings can sell quickly but…

👉 My subscribers skip the waitlist.*

^{*According to Masterworks data. Past performance is not indicative of future returns. Investing involves risk. Important Reg A disclosures: masterworks.com/cd.}

Inside the full breakdown, we dive into how healthcare uncertainty, interest-rate cycles, and defensive sector underperformance are reshaping dividend ETF valuations — and why some of the most durable income opportunities often appear when capital rotates away from stability in search of growth.

Let’s embark on this transformative journey together and position your portfolio for success in this evolving market landscape!

Be sure to read through to the end to catch all the valuable insights this newsletter delivers to your inbox today.

Picture this: Five years ago, Constellation Energy $CEG ( ▲ 7.9% ) stock traded around $45 per share. Today in May 2026, it closes at $267.20 — a strong +494% gain. The chart shows a steady climb with good acceleration in recent years, powered by rising electricity demand from data centers and clean energy needs. The 52-week high reached $412.70, showing the stock has already climbed much higher during strong periods.

Keeping it simple: The compound annual growth rate (CAGR) over these five years is about 43%. If this pace continues, it means strong yearly gains that compound powerfully over time.

Those requests came from non-traded BDC investors in Q1 2026, and most got back roughly half of what they asked for. Moody's U.S. BDC sector outlook: Negative.

On Percent's marketplace that same quarter: new issuances, scheduled payments, 0.44% lifetime net loss rate on asset-based deals since inception.† The difference is structural: concentrated corporate loans with redemption windows that close at manager discretion vs. asset-based finance with 6–24 month deal terms. 14.6% net ABS returns LTM after losses (3/31/26).† Starting at $500.

See how private credit works when it's built for individual investors.

_{Alternative investments are speculative. No assurance can be given that investors will receive a return of their capital. †Past performance is not indicative of future results. Terms apply.}

Now imagine using dollar-cost averaging (DCA): adding $500 every month for the next five years. This totals $30,000 invested from your pocket over 60 months. You buy more shares on dips and fewer on rises, which helps keep your average cost balanced.

If CEG follows a similar historical pace around 43% annual growth, your monthly $500 contributions could grow your investment to approximately $82,000 by the end of five years. That means a gain of roughly $52,000 beyond what you put in — a solid 173% overall return from consistent investing.

Past performance doesn't guarantee the future — energy prices, regulations, or market conditions can change the path.

But CEG is a major power generator with strong momentum from data center demand. Your $500 monthly plan stays simple and easy to maintain, letting compounding build real value.

The growing need for electricity keeps creating opportunities in this sector. Staying disciplined through any temporary pullbacks is what usually leads to good long-term results.

Ready to power your portfolio with this kind of potential?

In every strong market cycle, something predictable happens: attention floods into momentum, AI, and high-growth narratives while steady income strategies quietly drift into the background.

That is exactly what has unfolded recently.

Dividend ETFs—normally the backbone of conservative compounding strategies—have not disappeared, but many have been overshadowed by high-flying sectors that dominated capital flows. As a result, several high-quality income funds are now trading at discounts relative to their recent highs, even while underlying businesses remain stable.

This creates a very specific type of opportunity: not broken assets, but temporarily overlooked ones.

Five dividend-focused ETFs stand out in this environment. Each represents a different income strategy, risk profile, and sector exposure—but all share one important characteristic: they have lagged enough to re-enter the conversation for disciplined income investors.

Before examining them individually, two macro forces explain why this gap exists.

First, policy uncertainty in healthcare has triggered sharp volatility across defensive sectors, particularly after tariff-related concerns impacted pharmaceutical sentiment. Large, fundamentally strong healthcare companies were sold off not because of earnings deterioration, but because of headline-driven fear.

Second, capital rotation toward AI and growth equities has left defensive dividend strategies under-allocated. Historically, this imbalance does not persist indefinitely. When growth trades become crowded, capital eventually rebalances toward stability and yield.

That rotation process is already beginning to show up in pricing discrepancies across dividend ETFs.

SPLV represents one of the simplest income concepts in the market: own the least volatile stocks in the S&P 500 and accept lower upside in exchange for smoother performance.

Right now, SPLV is sitting in an unusual position relative to its peers. While broader categories surged double digits over the past year, SPLV lagged significantly, creating a gap of more than 20 percentage points versus high-performing segments of the market.

That divergence is not structural damage. It is a reflection of what SPLV holds and what the market rewarded during the AI-driven rally.

The ETF focuses heavily on:

Tech exposure remains minimal, which explains much of the underperformance during a technology-led cycle.

Key characteristics:

Core holdings typically include large, stable companies such as:

These are not companies built for explosive growth. They are built for predictable cash flow across economic cycles.

The important behavioral insight is this: SPLV tends to outperform when markets correct, not when markets expand aggressively. That makes it less exciting during rallies but significantly more stable during downturns.

For investors prioritizing income stability over capital acceleration, SPLV behaves more like a volatility buffer than a growth engine.

Healthcare is currently one of the most misunderstood areas in the dividend ETF landscape, largely due to policy-driven uncertainty rather than business deterioration.

Two major funds sit at the center of this opportunity:

Health Care Select Sector SPDR Fund
Vanguard Health Care ETF

Both ETFs have been pressured by fears tied to pharmaceutical tariffs and regulatory concerns. The market reaction has been sharp, but the underlying demand drivers remain structurally intact.

Healthcare demand is not cyclical in the traditional sense. It is primarily driven by:

XLV is the more concentrated version of the healthcare trade. It holds fewer companies but heavier weights in sector leaders.

Top exposures include:

This structure makes XLV more sensitive to large-cap pharma performance but also more responsive during recoveries.

Key features:

VHT expands the opportunity set significantly by holding hundreds of healthcare-related companies.

Instead of focusing primarily on large pharmaceutical firms, VHT includes:

Key features:

Where XLV is precision exposure, VHT is ecosystem exposure.

Both are currently trading below recent highs, but neither reflects weakening healthcare demand. Instead, pricing reflects temporary uncertainty around policy headlines.

Historically, healthcare drawdowns driven by policy fear—not earnings collapse—tend to recover once clarity returns.

PPH represents a more specialized approach to healthcare investing, focusing specifically on pharmaceutical companies rather than the broader healthcare ecosystem.

Unlike many lagging dividend ETFs, PPH has actually demonstrated relative strength within its category.

Performance characteristics show:

A key structural feature of PPH is its global composition. Roughly half of its holdings are international pharmaceutical companies, which reduces reliance on any single regulatory environment.

Another important factor is concentration in leading drug developers, including meaningful exposure to major innovators in metabolic and chronic disease treatments.

Key characteristics:

PPH behaves differently from XLV and VHT. Instead of broad healthcare exposure, it captures pharmaceutical innovation and pricing power more directly.

For income-focused investors, this creates a more targeted dividend stream with slightly higher sector concentration risk—but also stronger alignment with long-term pharmaceutical growth trends.

Among all five ETFs, MORT stands in a completely different category.

This is not a conservative dividend strategy. It is a high-yield income structure tied directly to interest rate cycles.

MORT currently offers one of the highest yields in the dividend ETF universe, near the 12% range, but that yield comes with elevated volatility and sensitivity to macroeconomic shifts.

The ETF holds mortgage REITs such as:

These companies operate by borrowing at short-term rates and investing in mortgage-backed assets, meaning their profitability is heavily influenced by Federal Reserve policy.

Key characteristics:

The central catalyst for MORT is a potential shift in interest rate policy in 2026. Historically, mortgage REITs tend to respond strongly when rate cycles begin easing, as borrowing costs stabilize and spreads improve.

However, this is also the most risk-sensitive ETF in the group.

This makes MORT a tool for:

Across all five ETFs, the opportunity is not about chasing yield blindly. It is about identifying where the market temporarily mispriced stability, policy risk, or interest rate expectations.

A simplified breakdown:

Each ETF solves a different problem inside a portfolio:

What ties them together is timing.

Dividend strategies rarely outperform during hype cycles. Their advantage emerges when markets begin rotating away from growth extremes and toward valuation discipline.

For overwhelmed investors, the key insight is simple:

Income investing is not about finding the highest yield.
It is about finding the most durable yield that still exists at a discount to historical expectations.

And right now, several of those opportunities are quietly sitting in sectors the market temporarily stopped paying attention to.

Ready to Revolutionize Your Wealth?

Here's what's waiting for you:

As the world becomes increasingly digital, this question will be on the minds of millions seeking new income streams in 2026.

The answer is—Absolutely!

Thank you for taking the time to read today’s email! Your support is what allows me to send out this newsletter for free every day. 

 What do you think of the new format? Please provide your feedback in the poll below, and if you find the newsletter valuable, feel free to share it with other investors!

Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Please consult with a financial advisor before making any investment decisions.